Literature DB >> 33145915

Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling.

Lu Tian1,2,3, Jinghui Gao1,2,3, Irving M Garcia1,2,3, Huanhuan Joyce Chen4,5, Alessandra Castaldi1,2,3, Ya-Wen Chen1,2,3,6.   

Abstract

The pulmonary system is comprised of two main compartments, airways and alveolar space. Their tissue and cellular complexity ensure lung function and protection from external agents, for example, virus. Two-dimensional (2D) in vitro systems and animal models have been largely employed to elucidate the molecular mechanisms underlying human lung development, physiology, and pathogenesis. However, neither of these models accurately recapitulate the human lung environment and cellular crosstalk. More recently, human-derived three-dimensional (3D) models have been generated allowing for a deeper understanding of cell-to-cell communication. However, the availability and accessibility of primary human cell sources from which generate the 2D and 3D models may be limited. In the past few years, protocols have been developed to successfully employ human pluripotent stem cells (hPSCs) and differentiate them toward pulmonary fate in vitro. In the present review, we discuss the advantages and pitfalls of hPSC-derived lung 2D and 3D models, including the main characteristics and potentials for these models and their current and future applications for modeling development and diseases. Lung organoids currently represent the closest model to the human pulmonary system. We further focus on the applications of lung organoids for the study of human diseases such as pulmonary fibrosis, infectious diseases, and lung cancer. Finally, we discuss the present limitations and potential future applications of 3D lung organoids. This article is categorized under: Adult Stem Cells, Tissue Renewal, and Regeneration > Stem Cells and Disease Adult Stem Cells, Tissue Renewal, and Regeneration > Stem Cell Differentiation and Reversion.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  disease modeling; human pluripotent stem cell; lung differentiation; lung organoid; lung spheroid

Mesh:

Year:  2020        PMID: 33145915     DOI: 10.1002/wdev.399

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Dev Biol        ISSN: 1759-7684            Impact factor:   5.814


  11 in total

Review 1.  'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension.

Authors:  Emilia M Swietlik; Matina Prapa; Jennifer M Martin; Divya Pandya; Kathryn Auckland; Nicholas W Morrell; Stefan Gräf
Journal:  Genes (Basel)       Date:  2020-11-26       Impact factor: 4.096

2.  Comparing α-Quartz-Induced Cytotoxicity and Interleukin-8 Release in Pulmonary Mono- and Co-Cultures Exposed under Submerged and Air-Liquid Interface Conditions.

Authors:  Alexandra Friesen; Susanne Fritsch-Decker; Matthias Hufnagel; Sonja Mülhopt; Dieter Stapf; Andrea Hartwig; Carsten Weiss
Journal:  Int J Mol Sci       Date:  2022-06-08       Impact factor: 6.208

Review 3.  Harnessing organs-on-a-chip to model tissue regeneration.

Authors:  Daniel Naveed Tavakol; Sharon Fleischer; Gordana Vunjak-Novakovic
Journal:  Cell Stem Cell       Date:  2021-06-03       Impact factor: 25.269

Review 4.  Three-Dimensional Cell Culture Models to Study Respiratory Virus Infections Including COVID-19.

Authors:  Aya Harb; Mohammad Fakhreddine; Hassan Zaraket; Fatima A Saleh
Journal:  Biomimetics (Basel)       Date:  2021-12-25

Review 5.  3D Bioprinting Strategies, Challenges, and Opportunities to Model the Lung Tissue Microenvironment and Its Function.

Authors:  Mabel Barreiro Carpio; Mohammadhossein Dabaghi; Julia Ungureanu; Martin R Kolb; Jeremy A Hirota; Jose Manuel Moran-Mirabal
Journal:  Front Bioeng Biotechnol       Date:  2021-11-24

6.  CoQ10 enhances the efficacy of airway basal stem cell transplantation on bleomycin-induced idiopathic pulmonary fibrosis in mice.

Authors:  Huanbin Liu; Shuna Liu; Jinjun Jiang; Yidi Zhang; Yulong Luo; Jingxin Zhao; Jian Xu; Yuan Xie; Weiping Liao; Wei Wang; Yichu Nie; Shiyue Li; Wenbin Deng
Journal:  Respir Res       Date:  2022-02-26

Review 7.  Lung Organoids-The Ultimate Tool to Dissect Pulmonary Diseases?

Authors:  Veronika Bosáková; Marco De Zuani; Lucie Sládková; Zuzana Garlíková; Shyam Sushama Jose; Teresa Zelante; Marcela Hortová Kohoutková; Jan Frič
Journal:  Front Cell Dev Biol       Date:  2022-07-13

8.  A Barrier to Defend - Models of Pulmonary Barrier to Study Acute Inflammatory Diseases.

Authors:  Anna Herminghaus; Andrey V Kozlov; Andrea Szabó; Zoltán Hantos; Severin Gylstorff; Anne Kuebart; Mahyar Aghapour; Bianka Wissuwa; Thorsten Walles; Heike Walles; Sina M Coldewey; Borna Relja
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

9.  SOX9 inactivation affects the proliferation and differentiation of human lung organoids.

Authors:  Lian Li; Jianqi Feng; Shanshan Zhao; Zhili Rong; Ying Lin
Journal:  Stem Cell Res Ther       Date:  2021-06-10       Impact factor: 6.832

Review 10.  In Vitro Systems for Toxicity Evaluation of Microbial Volatile Organic Compounds on Humans: Current Status and Trends.

Authors:  Kustrim Cerimi; Udo Jäckel; Vera Meyer; Ugarit Daher; Jessica Reinert; Stefanie Klar
Journal:  J Fungi (Basel)       Date:  2022-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.